Comparison of medications for heart failure finds difference in risk of death
Tuesday, January 11, 2011 - 17:00
in Health & Medicine
In a comparison of the angiotensin II receptor blockers (ARBs) candesartan and losartan, used by patients with heart failure, candesartan was associated with a lower risk of death at 1 and 5 years, according to a study in the January 12 issue of JAMA.